CAR-T Cell Therapy in First Line for High Risk Diffuse Large B-Cell Lymphoma: Review of Efficacy and CostEffectiveness Against Standard of Care Chemo-Immunotherapy

被引：3
|
作者：
Akbar, Usman Ali [1 ]
Rashid, Zaraq [2 ]
Rehman, Zarlish [3 ]
Alam, Shehzad [4 ]
Altaf, Zooha [5 ]
Anwar, Rana Usman [6 ]
Khan, Adil [6 ]
Wakeel, Jafir [6 ]
Farooq, Saad [7 ]
Khan, Muhammad Haris [8 ]
Safi, Danish [9 ]
Inayat, Arslan [10 ]
Safi, Salah Ud Din [9 ]
机构：
[1] Northwell Hlth, Dept Internal Med, New York, NY USA
[2] LRH, Peshawar, Pakistan
[3] Hayatabad Med Complex, Peshwar, Pakistan
[4] Khyber Teaching Hosp, Peshawar, Pakistan
[5] Eastern Virginia Med Sch, Norfolk, VA 23501 USA
[6] Univ Louisville, Louisville, KY 40292 USA
[7] Nishtar Med Univ, Multan, Pakistan
[8] Univ Louisiana, Div Infect Dis, Shreveport, LA USA
[9] West Virginia Univ, Morgantown, WV 26506 USA
[10] Univ Buffalo, Buffalo, NY USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-170669
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12052 / 12054
页数：3
相关论文
共 50 条
  • [41] Prognostic Value of cMYC Gene Abnormalities in Diffuse Large B Cell Lymphoma Treated with Chemo-Immunotherapy
    Battle Lopez, Ana
    Glez de Villambrosia, Sonia
    Montes-Moreno, Santiago
    Mazorra, Francisco
    Insunza, Andres
    Saez, Anabel
    Montalban, Carlos
    Sanchez, Lydia
    Garcia, Juan F.
    Gonzalez-Barca, Eva
    Lopez, A.
    Ruiz-Marcellan, M. C.
    Mollejo, Manuela
    Grande, Carlos
    Dunphy, Cherie H.
    His, E. D.
    Go, Ronald S.
    Visco, Carlo
    Xu-Monette, Zijun Y.
    Young, Ken H.
    Piris, Miguel
    Conde, Eulogio, Sr.
    BLOOD, 2011, 118 (21) : 1144 - 1144
  • [42] Diffuse large B-cell lymphoma and neurotoxicity following CAR-T cell immunotherapy: Contributing factors and blood-brain barrier impairment biomarkers
    Vidal-Lartitegui, Leticia
    Herreros-Pomares, Alejando
    Cervera, Raimundo
    Simarro, Silvia
    Tebar, Roberto
    Hernani, Rafael
    Benzaquren, Ana
    Terol, Maria Jose
    Solano, Carlos
    Vidal-Vanaclocha, Fernando
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [43] Role of interim PET/CT as predictor of outcome in newly diagnosed diffuse large b-cell lymphoma in the chemo-immunotherapy era
    Damlaj, Moussab
    Jaber, Waed
    Al Najjar, Afnan
    Altamimi, Sumayyah
    Al Onazi, Tarfa
    Alzayed, Mohammed
    Damlaj, Ahmad
    Yassin, Rehab
    Alahmari, Bader
    Alhejazi, Ayman
    Gmati, Giamal
    Abuelgasim, Khadega
    Salama, Hind
    Alaskar, Ahmed
    Al Zahrani, Mohsen
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (03)
  • [44] Second-line Treatment With CAR T-Cell Therapy for Large B-Cell Lymphoma
    Lutfi, Forat
    Patel, Ameet
    Mehta, Jasmine
    Goyal, Anmol
    Dahiya, Saurabh
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (04) : 170 - 178
  • [45] Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma
    Sim, Austin J.
    Jain, Michael D.
    Figura, Nicholas B.
    Chavez, Julio C.
    Shah, Bijal D.
    Khimani, Farhad
    Lazaryan, Aleksandr
    Krivenko, Gabriel
    Davila, Marco L.
    Liu, Hien D.
    Falchook, Aaron D.
    Dahiya, Saurabh
    Rapoport, Aaron P.
    Kim, Sungjune
    Locke, Frederick L.
    Robinson, Timothy J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (05): : 1012 - 1021
  • [46] CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma
    Khan, Salman J.
    Moustafa, Muhamad Alhaj
    CHINESE CLINICAL ONCOLOGY, 2024, 13 (02)
  • [47] Chemo-immunotherapy dosing in older patients with diffuse large B-cell lymphoma: is this how we should treat our parents?
    Link, Brian K.
    LEUKEMIA & LYMPHOMA, 2012, 53 (08) : 1435 - 1436
  • [48] CAR T-cell therapy in refractory large B-cell lymphoma
    Stirrups, Robert
    LANCET ONCOLOGY, 2018, 19 (01): : E19 - E19
  • [49] Prediction Modeling of CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma Using Artificial Neural Networks on Tumor Vascular Phenotype
    Verma, Anuj
    Liburd, Samuel
    Tobias, Zsuzsanna
    Isufi, Iris
    Pober, Jordan
    Xu, Mina L.
    BLOOD, 2023, 142
  • [50] Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy
    Di Rocco, Alice
    Cuneo, Antonio
    Di Rocco, Arianna
    Merli, Francesco
    De Luca, Giulia
    Petrucci, Luigi
    Ansuinelli, Michela
    Penna, Domenico
    Rotondo, Francesco
    Rigolin, Gian Matteo
    Giamo, Mariateresa
    Re, Francesca
    Farcomeni, Alessio
    Martelli, Maurizio
    Foa, Robin
    LEUKEMIA & LYMPHOMA, 2021, 62 (04) : 828 - 836
12345